Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
This review aims to provide an overview of the current knowledge of the genetic lesions driving pediatric acute myeloid leukemia (AML), emerging biological concepts, and strategies for therapeutic intervention. Hereby, we focus on lesions that preferentially or exclusively occur in pediatric patient...
Main Authors: | Thomas Mercher, Juerg Schwaller |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2019.00401/full |
Similar Items
-
Corrigendum: Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
by: Thomas Mercher, et al.
Published: (2019-11-01) -
Straight to the Point—The Novel Strategies to Cure Pediatric AML
by: Monika Lejman, et al.
Published: (2022-02-01) -
Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia
by: Piotr Obszański, et al.
Published: (2022-06-01) -
High-Risk Acute Myeloid Leukemia: A Pediatric Prospective
by: Fabiana Cacace, et al.
Published: (2022-06-01) -
Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)
by: Ziyang Cao, et al.
Published: (2022-11-01)